Clinical trial
A Pilot Study to Evaluate 18F Florbetapir Binding to Cardiac Amyloid in Patients Undergoing Chemotherapy
NCT03333551 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study to Evaluate 18F Florbetapir Binding to Cardiac Amyloid in Patients Undergoing Chemotherapy
- Lead sponsor
- Medical College of Wisconsin
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- October 1, 2020
- Completion date
- May 8, 2023
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiac amyloidosis